Discover our podcast session containing seven tracks on Identifying and mitigating risks in the viral vector supply chain featuring Claire Wartel, PhD, Director of Quality and Compliance at Polyplus-transfection and Ulises Villavicencio, Quality Auditor at Audentes Therapeutics.

Interviewees: Claire Wartel & Ulises Villavicencio

These two experts discussed:

  • Critical pain points for cell and gene therapy companies
  • The importance of the quality of raw materials
  • The GMP subject in a manufacturing process
  • Quality requirements needed from regulatory agencies
  • The complexity of the cell & gene supply chain
  • Polyplus’ assets in this challenging environment

Get the PDF version